Non-alcoholic Fatty Liver Disease
📧 Sign up to get email alerts when something new happens for Non-alcoholic Fatty Liver Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2024-06-21Clinical Trial Update: Metabolic Subtypes of Non-Alcoholic Fatty Liver Disease
Clinical trial update focusing on metabolic subtypes of Non-Alcoholic Fatty Liver Disease; the current trial status is UNKNOWN.
-
CLINICAL_TRIALS withdrawal · 2024-06-20Clinical Trial Update: Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BAR 502 in Healthy Subjects [Phase 1]
This Phase 1 trial of BAR 502 in healthy subjects intended for non-alcoholic fatty liver disease was withdrawn.
-
CLINICAL_TRIALS trial_result · 2024-06-13Clinical Trial Update: Focused Power Ultrasound Mediated Inferior Perirenal Adipose Tissue Modification Therapy for Non-Alcoholic Fatty Liver Disease (PARADISE-NAFLD) [NA]
A clinical trial update for PARADISE-NAFLD assessing focused power ultrasound–mediated modification of inferior perirenal adipose tissue as …
-
CLINICAL_TRIALS trial_result · 2024-06-11Clinical Trial Update: A Research Study Looking at How a Single Dose of the Medicine NNC0194-0499 Behaves in Chinese Men [Phase 1]
Phase 1 pharmacokinetics study assessing a single dose of NNC0194-0499 in Chinese men with non-alcoholic fatty liver disease has been comple…
-
CLINICAL_TRIALS research · 2024-06-10Clinical Trial Update: Aronia and Non-alcoholic Fatty Liver Disease [NA]
This clinical trial registry entry describes testing Aronia extract for non-alcoholic fatty liver disease. The study is not yet recruiting.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-06-06Clinical Trial Update: The Metabolic Impact of Intermittent Carbohydrate Restriction in Individuals With Type 2 Diabetes [NA]
A clinical trial is evaluating the metabolic effects of intermittent carbohydrate restriction in adults with type 2 diabetes; recruitment is…
-
CLINICAL_TRIALS research · 2024-06-04Clinical Trial Update: Comparison Between the Efficacy of Residential and Ambulatory Weight Loss Programs for Pediatric Non-alcoholic Fatty Liver Disease
Ongoing pediatric trial comparing residential versus ambulatory weight loss programs for non-alcoholic fatty liver disease. The study aims t…
-
CLINICAL_TRIALS trial_result · 2024-05-31Clinical Trial Update: Determination of Biological Activity of Enriched Serum Following TOTUM-448 Consumption [NA]
Completed clinical trial update evaluating the biological activity of serum enriched after TOTUM-448 consumption, in the context of NAFLD an…
-
CLINICAL_TRIALS research · 2024-05-24Clinical Trial Update: Effects of Almonds in Glucose-intolerant Adults (AGAMEMNON) [NA]
Clinical trial evaluating the effects of almond consumption on glucose tolerance in adults with prediabetes and non-alcoholic fatty liver di…
-
CLINICAL_TRIALS trial_result · 2024-05-17Clinical Trial Update: Study of Semaglutide for Non-Alcoholic Fatty Liver Disease (NAFLD), a Metabolic Syndrome With Insulin Resistance, Increased Hepatic Lipids, and Increased Cardiovascular Disease Risk (The SLIM LIVER Study) [Phase 2]
Phase 2 study of semaglutide for non-alcoholic fatty liver disease in HIV infection completed, with results posted in May 2024.
-
CLINICAL_TRIALS research · 2024-05-16Clinical Trial Update: MRI and Stable Isotope Tracer Studies for Detecting the Progression of Non-Alcoholic Steatohepatitis (NASH)
University of Oxford reports an MRI and stable isotope tracer study aimed at detecting progression of non-alcoholic steatohepatitis (NASH) w…
-
CLINICAL_TRIALS trial_result · 2024-05-14Clinical Trial Update: Different Doses of ZED1227 vs. Placebo in NAFLD [Phase 2]
Phase 2 trial comparing different doses of ZED1227 to placebo in non-alcoholic fatty liver disease with liver fibrosis; the study has comple…
-
CLINICAL_TRIALS research · 2024-05-14Clinical Trial Update: Hepatic Urea Nitrogen Handling in Patients With NASH
A clinical trial update describing a study on hepatic urea nitrogen handling in patients with non-alcoholic fatty liver disease, including n…
-
CLINICAL_TRIALS research · 2024-05-14Clinical Trial Update: Effectiveness of Bariatric Surgery for NAFLD/NASH
A clinical trial from Beijing Friendship Hospital is assessing the effectiveness of bariatric surgery for non-alcoholic fatty liver disease …
-
CLINICAL_TRIALS trial_result · 2024-05-10Clinical Trial Update: Efficacy and Safety of Tocovid Suprabio 200mg in Non-alcoholic Fatty Liver (NAFL) [Phase 2]
Phase 2 trial evaluating the efficacy and safety of Tocovid Suprabio 200mg in hepatic steatosis and non-alcoholic fatty liver disease has co…
-
CLINICAL_TRIALS trial_result · 2024-05-09Clinical Trial Update: Liver, Diet and Genetic Background [NA]
A completed clinical trial update from the University of Eastern Finland examining how diet and genetic background influence liver fat.
-
CLINICAL_TRIALS research · 2024-05-08Clinical Trial Update: Ambulatory Liver Fat Monitoring in Patients With Non-alcoholic Fatty Liver Disease [NA]
This clinical trial update notes ongoing recruitment for ambulatory liver fat monitoring in adults with Non-Alcoholic Fatty Liver Disease. T…
-
CLINICAL_TRIALS trial_result · 2024-05-08Clinical Trial Update: Electrical Impedance Tomography in Fatty Liver Detection
The University of Hong Kong completed a clinical trial evaluating electrical impedance tomography as a non-invasive method for detecting non…
-
CLINICAL_TRIALS research · 2024-05-08Clinical Trial Update: Smartphone App for Non-alcoholic Fatty Liver Disease [NA]
The University of Hong Kong is sponsoring a smartphone app trial for non-alcoholic fatty liver disease, and recruitment is ongoing.
-
CLINICAL_TRIALS research · 2024-05-07Clinical Trial Update: A Prospective, Randomized, Open Label Trial of Two Doses of Oral Betaine [NA]
A prospective, randomized, open-label trial comparing two oral doses of betaine in participants with non-alcoholic fatty liver disease and n…
-
CLINICAL_TRIALS research · 2024-05-03Clinical Trial Update: Dietary Supplementation With Butyrate in Individuals With Liver Steatosis and Metabolic Syndrome [NA]
A completed clinical trial evaluating dietary supplementation with butyrate in individuals with non-alcoholic fatty liver disease and metabo…
-
CLINICAL_TRIALS research · 2024-05-02Clinical Trial Update: Deep Phenotyping of Peripheral Blood Cells and Circulating Factors in Metabolic Diseases
This clinical trial from Technische Universität Dresden aims to deeply phenotype peripheral blood cells and circulating factors in metabolic…
-
CLINICAL_TRIALS trial_result · 2024-04-29Clinical Trial Update: A Phase 1 Study of DD01 in Overweight/Obese Subjects With T2DM and NAFLD [Phase 1]
Phase 1 study of DD01 in overweight/obese adults with Type 2 diabetes and non-alcoholic fatty liver disease has completed.
-
CLINICAL_TRIALS trial_result · 2024-04-26Clinical Trial Update: Effect of a Food Supplementation With a Combined Food Supplement on Lipid Pattern, Indexes of Non-alcoholic Fatty Liver Disease and Systemic Inflammation [NA]
This clinical trial update reports the completion of a study evaluating the effect of a combined food supplement on lipid profiles, non-alco…
-
CLINICAL_TRIALS trial_result · 2024-04-17Clinical Trial Update: Post-Prandial Liver Glucose Metabolism in PCOS
Post-prandial liver glucose metabolism study in women with polycystic ovarian syndrome (PCOS) and obesity; trial completed with results post…